HomeOpen Access NewsSH - IOZK Immun-Onkologisches Zentrum Köln

SH - IOZK Immun-Onkologisches Zentrum Köln

Individualised Multimodal Immunotherapy beyond personalised medicine for brain cancer

Stefaan Van Gool, MD, PhD brings to light the important role of Individualised Multimodal Immunotherapy in improving the survival of brain cancer.

No posts to display

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders